v3 Template
V

Varro Holdings, Inc.

Healthcare and Biotechnology ~620 employees
Founded
--
Employees (Est.)
~620
31 leaders known
Total Funding
$20.0M
Funding Rounds
1
Last Funding
2024-10-31

About Varro Holdings, Inc.

Varro Life Sciences is dedicated to disrupting disease transmission by developing innovative products and technologies that have a global impact. Their mission is to leverage technology to save lives, ensure safe environments, and prevent future pandemics. Established in January 2020 as Y2X Life Sciences, the company rebranded to Varro Life Sciences in October 2024.

Products & Services

Micro Immunoelectrodes (MIE):A customizable electrochemical biosensor using nanobodies for rapid pathogen or allergen detection with higher specificity than PCR, delivering results in 60 seconds.
Breath Based Diagnostic:A non-invasive diagnostic tool providing accurate results in 60 seconds, designed for ease of use without specialized training, validated through peer-reviewed studies.
Air Bio-Detector:A device using nanobodies and MIEs to detect viral, fungal, or bacterial pathogens in the air, monitoring 1 to 100 targets with minimal maintenance for early detection in public spaces and supply chains.

Specialties

Pathogen Detection Biosensor Technology Aerosol Engineering Microbiology Non-Invasive Diagnostics

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Non-dilutive funding
T: -
FT: Non-dilutive funding
A: 20000000
MR: -
FA: 20 million USDC
FAN: 20000000
D: 2024-10-31
FD: 2024-10-31
1 investors
Non-dilutive funding Latest
2024-10-31
$20.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

T

Tom Cirrito

Chief Executive Officer

LinkedIn (Pro only)
D

David Shuler

President

LinkedIn (Pro only)
J

Jim Shapiro

Chief Operating Officer

LinkedIn (Pro only)
B

Brad Theien

Chief Revenue Officer

M

Maurizio Arienzo

Chief Innovation Officer

P

Patricia Olinger

Chief Relationship Officer

View 28 more team members with Pro

Unlock Full Team Directory

Recent News

Varro Holdings, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare and Biotechnology
Company Size
~620 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro